Volume 94, supplement 6, Suppl. FMC numéro 7 : Thérapeutiques ciblées : malades sélectionnés

Formation SFC

Thérapeutiques ciblées : malades sélectionnés (p.99)
Jacques Robert

What is a targeted therapy ? The view of the biologist (p.101-10)
Jacques Robert

Targeted therapy : what does it mean ? A physician point of view (p.111-4)
Jean-Philippe Spano

Molecular modelling and drug design (p.115-27)
Michel Laguerre

Target antigens for therapeutic antibodies in oncology: many candidates, few sucesses (p.129-36)
Nicolas Ceze, Alicia Probst, Thierry Lecomte, Marc Ohresser, Gilles Paintaud, Hervé Watier

Growth factors of the EGF family and their receptors (p.137-45)
Pierre Hubert

Targeting ErbB receptors in breast cancer (p.147-70)
Pierre Fumoleau, Mario Campone, Bruno Coudert, Françoise Mayer, Laure Favier, Emanuelle Ferrant

EGF receptors in colorectal cancers (p.171-6)
Jean-Philippe Spano, Stéphane Vignot

Targeting epidermal growth factor receptor in non-small cell lung cancer : current advances and perspectives (p.177-88)
Antoine Italiano, Benjamin Besse, David Planchard, Jean-Charles Soria

Epidermal growth factor receptor (EGF) in head-and-neck cancers (p.189-91)
J Bourhis, YG Tao, P Zhang, E Deutsch

Tumor angiogenesis (p.193-8)
Andreas Bikfalvi

Angiogenesis targeting in breast cancer (p.199-206)
Pierre Fumoleau, Bruno Coudert, Françoise Mayer, Nicolas Isambert, Laure Favier, Emmanuelle Ferrant

Angiogenesis targeting in gastro-intestinal cancers (p.207-15)
Jean-Baptiste Meric

Angiogenesis targeting in lung cancers (p.217-22)
David Planchard, Benjamin Besse

Angiogenesis targeting in renal carcinomas (p.223-6)
Damien Pouessel, Stephane Culine

Predictive factors of response to targeted therapies: the example of colorectal cancer (p.227-30)
Gérard Milano

Evaluation of tumour response to treatment with targeted therapies : standard or targeted criteria ? (p.231-9)
Yves Menu

Therapeutic response evaluation by nuclear functional imaging (p.241-4)
Jean-Luc Moretti, Elif Hindie, Laetitia Vercellino

Targeted therapies: the question of target detection and evaluation (p.245-8)
Frédérique Penault-Llorca